Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Nov 24, 2021
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adamas Pharmaceuticals Inc
| -10.00K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -117.78K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -525.00K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -145.02K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -4.63M |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -168.04K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -20.98K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -25.00K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -21.00K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -202.00K |
—
|
—
| -100.00% |
0
|
Nov 24
| |||||||
Adamas Pharmaceuticals Inc
| -6.20K |
$5.16 | -$31,982.70 | -3.61% | 165.74K |
Jun 21
| |||||||
Adamas Pharmaceuticals Inc
| -2.00K |
$5.17 | -$10,340.00 | -20.00% | 8K |
Jun 7
|
Scheduled
| ||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +25.00% | 25K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +31.30% | 20.98K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +4.54% | 115.15K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +2.54% | 202K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +100.00% | 10K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +100.00% | 10K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +100.00% | 10K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +100.00% | 10K |
Jun 2
| |||||||
Adamas Pharmaceuticals Inc
| -1.05K |
$5.50 | -$5,780.50 | -0.62% | 169.44K |
Mar 22
| |||||||
Adamas Pharmaceuticals Inc
| -2.42K |
$5.48 | -$13,272.56 | -1.64% | 145.02K |
Mar 22
| |||||||
Adamas Pharmaceuticals Inc
| 48K |
$0.67 | $31,920.00 | +77.23% | 110.15K |
Mar 12
| |||||||
Adamas Pharmaceuticals Inc
| 192K |
$0.67 | $127,680.00 | +3,840.00% | 197K |
Mar 12
| |||||||
Adamas Pharmaceuticals Inc
| 5.97K |
$5.06 | $30,233.50 | +59.75% | 15.97K |
Mar 11
| |||||||
Adamas Pharmaceuticals Inc
| 300K |
—
|
—
| +133.33% | 525K |
Mar 2
| |||||||
Adamas Pharmaceuticals Inc
| 75K |
—
|
—
| +78.55% | 170.49K |
Mar 2
| |||||||
Adamas Pharmaceuticals Inc
| 75K |
—
|
—
| +103.54% | 147.44K |
Mar 2
| |||||||
Adamas Pharmaceuticals Inc
| -3.82K |
$6.36 | -$24,301.56 | -5.01% | 72.44K |
Feb 1
| |||||||
Adamas Pharmaceuticals Inc
| -4.51K |
$6.39 | -$28,844.46 | -4.51% | 95.49K |
Feb 1
| |||||||
Adamas Pharmaceuticals Inc
| -2.63K |
$4.41 | -$11,598.30 | -3.33% | 76.26K |
Jan 20
| |||||||
Adamas Pharmaceuticals Inc
| 10K |
—
|
—
|
∞
| 10K |
Nov 22
| |||||||
Adamas Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adamas Pharmaceuticals Inc
| -2.05K |
$3.21 | -$6,580.50 | -2.53% | 78.89K |
Nov 2
| |||||||
Adamas Pharmaceuticals Inc
| 10K |
—
|
—
| +100.00% | 20K |
Aug 29
| |||||||
Adamas Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
|
∞
| 5K |
Jun 3
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +10.42% | 53K |
Jun 3
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
| +8.75% | 62.15K |
Jun 3
| |||||||
Adamas Pharmaceuticals Inc
| 5K |
—
|
—
|
∞
| 5K |
Jun 3
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.